Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

Pfizer Ends Drug Cards For Elderly

Article Abstract:

Pfizer Corp. has discontinued its senior citizen discount program; the company says it warned customers and gave them enough time to switch plans, but consumer advocates argue that it would have been more ethical to wait until 2006 when customers were automatically covered by new Medicare laws.

Author: Freudenheim, Milt
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Services discontinued, Panama, Ethics, Health aspects, Economic aspects, Ethical aspects, Medicare, Pfizer Corp., Service discontinuation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug Lobby Got a Victory in Trade Pact Vote

Article Abstract:

The pharmaceutical industry has successfully lobbied for patent rights and market exclusivity extending for five years, as part of the Central American Free Trade Agreement.

Author: Saul, Stephanie
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
Marketing procedures, Global Marketing, Patents & copyrights, Public Relations Agencies, Public relations services, Lobbyists, Interpretation and construction, Political activity, Intellectual property, Commercial treaties, Trade agreements, International marketing, Pharmaceutical Research and Manufacturers of America

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A Blow to Efforts To Close In on Rivals

Article Abstract:

Merck and Company is expected to be hit hard financially by the withdrawal of its popular arthritis and pain medication Vioxx.

Author: Freudenheim, Milt
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Sales, profits & dividends, Market share, Securities issued, listed, Product discontinued, Securities, Company sales and earnings, Company earnings/profit, Company securities, Company market share, Product discontinuation, Merck & Company Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Pharmaceutical industry, Prices and rates, Company pricing policy
Similar abstracts:
  • Abstracts: Miners go for green. Down and dirty in datacasting
  • Abstracts: Sorry for Lies, Rowland Asks For Forgiveness. Rowland Opponent Has His Day in the Sun. Bill Allows Sales of Pill Over Counter
  • Abstracts: Big Blue's Big Bet: Less Tech, More Touch. Doctors' Journal Says Computing Is No Panacea
  • Abstracts: China Goes Beyond Oil in Forging Ties to Persian Gulf. Let a Thousand Ideas Flower: China Is a New Hotbed of Research
  • Abstracts: The Troubling Case of the Phantom Readers. Media Timing and the October Surprise. Ads Embedded In Online News Raise Questions
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.